Elias Campo
Professor of Pathology
Hospital Clinic de Barcelona / University of Barcelona · Barcelona, Spain
World authority on MCL pathology. Led the WHO classification of lymphoid neoplasms. Defined the molecular subtypes of MCL including leukemic non-nodal MCL.
Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.
Leukemia · Mar 1, 2026
The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma.
Scientific reports · Feb 7, 2026
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.
HemaSphere · Oct 1, 2025
The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma.
Blood cancer journal · Jul 30, 2025
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
The Journal of clinical investigation · Mar 17, 2025
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.
Blood advances · Dec 24, 2024
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
Blood cancer journal · Sep 23, 2024
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features.
Blood · Jul 11, 2024
Author Correction: SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
Scientific reports · Jun 11, 2024
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
The Journal of clinical investigation · May 15, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
Blood · May 9, 2024
SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
Scientific reports · Apr 3, 2024
An atlas of cells in the human tonsil.
Immunity · Feb 13, 2024
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
British journal of haematology · Jan 1, 2024